HomeCompareXPHYF vs ADC

XPHYF vs ADC: Dividend Comparison 2026

XPHYF yields 705.11% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XPHYF wins by $964927.19M in total portfolio value
10 years
XPHYF
XPHYF
● Live price
705.11%
Share price
$0.28
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$964927.37M
Annual income
$754,446,983,210.15
Full XPHYF calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — XPHYF vs ADC

📍 XPHYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXPHYFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XPHYF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XPHYF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XPHYF
Annual income on $10K today (after 15% tax)
$59,934.07/yr
After 10yr DRIP, annual income (after tax)
$641,279,935,728.63/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, XPHYF beats the other by $641,279,867,050.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XPHYF + ADC for your $10,000?

XPHYF: 50%ADC: 50%
100% ADC50/50100% XPHYF
Portfolio after 10yr
$482463.78M
Annual income
$377,223,532,003.72/yr
Blended yield
78.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

XPHYF
No analyst data
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XPHYF buys
0
ADC buys
0
No recent congressional trades found for XPHYF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXPHYFADC
Forward yield705.11%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$964927.37M$178.9K
Annual income after 10y$754,446,983,210.15$80,797.29
Total dividends collected$947907.97M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: XPHYF vs ADC ($10,000, DRIP)

YearXPHYF PortfolioXPHYF Income/yrADC PortfolioADC Income/yrGap
1← crossover$81,211$70,510.67$10,990$580.36+$70.2KXPHYF
2$622,056$535,160.68$12,301$860.26+$609.8KXPHYF
3$4,496,642$3,831,041.55$14,104$1,298.62+$4.48MXPHYF
4$30,693,047$25,881,640.63$16,691$2,008.16+$30.68MXPHYF
5$197,946,383$165,104,822.52$20,580$3,205.09+$197.93MXPHYF
6$1,206,941,168$995,138,538.05$26,754$5,330.02+$1206.91MXPHYF
7$6,962,148,280$5,670,721,230.88$37,196$9,345.14+$6962.11MXPHYF
8$38,020,642,481$30,571,143,821.30$56,244$17,523.09+$38020.59MXPHYF
9$196,710,644,881$156,028,557,426.06$94,286$35,736.21+$196710.55MXPHYF
10$964,927,373,233$754,446,983,210.15$178,949$80,797.29+$964927.19MXPHYF

XPHYF vs ADC: Complete Analysis 2026

XPHYFStock

BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Full XPHYF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this XPHYF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XPHYF vs SCHDXPHYF vs JEPIXPHYF vs OXPHYF vs KOXPHYF vs MAINXPHYF vs NNNXPHYF vs EPRTXPHYF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.